Biotech Growth Trust (The) (BIOG)

Business description

The Biotech Growth Trust seeks capital appreciation through investing in the worldwide biotechnology industry, mainly in emerging biotechnology companies. Performance is measured against its benchmark index, the NASDAQ Biotechnology Index (sterling adjusted).

Stock data

Market cap.£415.9m
Last close744.75p
High / Low (52 weeks)781.0p / 564.0p
Stock market listingLN
Forecast net debt (m)N/A
Forecast gearing ratio (%)N/A
TeamInvestment Companies
SectorInvestment Companies

Other companies in sector Show

Aberdeen New Dawn Investment Trust Aberdeen New Thai Investment Trust
Aberdeen Private Equity Fund Aberdeen UK Tracker Trust
AcenciA Debt Strategies Acorn Income Fund
Alliance Trust Altamir SCA
Amphion Innovations Aurelius
Bailador Tech Investments Bankers Investment Trust (The)
BB Biotech BlackRock Greater Europe Investment Trust
BlackRock Hedge Selector BlackRock Latin American Inv. Trust
British Portfolio Trust Brunner Investment Trust (The)
Canadian General Investments Carador Income Fund
Charles Stanley City Natural Resources
Conversus Capital CQS Rig Finance Fund
CVC Credit Partners Detour Gold
Deutsche Beteiligungs Dexion Commodities
Diverse Income Trust (The) DouglasBay Capital
Dunedin Enterprise Investment Trust DW Catalyst Fund
Edinburgh Worldwide Investment Trust (The) European Assets Trust
European Investment Trust Plc (The) F&C Managed Portfolio Trust
F&C US Smaller Companies Fidelity China Special Situations
Fidelity European Values Finsbury Growth & Income Trust
Foreign & Colonial Investment Trust Gartmore Growth Opportunities
Gartmore Irish Growth Fund Geiger Counter Limited
GLI Alternative Finance Global Resources Investment Trust
Golden Prospect Precious Metals Hansa Trust
HarbourVest Global Private Equity HarbourVest Senior Loans Europe
HBM Healthcare Investments Heliad Equity Partners
Henderson Alternative Strategies Trust Henderson Far East Income Limited
Henderson Global Trust Henderson Global Trust
Henderson International Income Trust HSBC Infrastructure Company
Infrastructure India International Biotechnology Trust
Invesco Asia Trust Invesco Income Growth Trust
Is Private Equity JP Morgan Private Equity Limited
JPMorgan Brazil Investment Trust JPMorgan European Smaller Companies Trust
JPMorgan Global Convertibles Income Fund JPMorgan Global Growth & Income
JPMorgan Indian Investment Trust Jupiter Green Investment Trust
Jupiter UK Growth Investment Trust Jupiter US Smaller Companies
JZ Capital Partners Limited Lazard World Trust Fund
Leaf Clean Energy Company LMS Capital
Lowland Investment Company PLC LPEQ
Martin Currie Asia Unconstrained Trust Martin Currie Global Portfolio Trust
Middlefield Canadian Income Miton Global Opportunities
Miton Income Opportunities Trust New City Energy
Ocean Wilsons Holdings Pacific Assets Trust
Phaunos Timber Fund Polar Capital Global Healthcare Growth and Income Trust
PXP Vietnam Fund Qatar Investment Fund
Rathbone Brothers RENN Universal Growth Investment Trust
Schroder AsiaPacific Fund Schroder Global Real Estate Securities
Scottish Oriental Smaller Companies Trust Securities Trust of Scotland
Seneca Global Income & Growth Trust Sigma Capital Group
Standard Life Equity Income Trust Standard Life Investments Property Income Trust
Standard Life Pvt. Equity Trust Standard Life UK Smaller Companies Trust
Strategic Equity Capital Taiwan Fund (The)
Templeton Emerging Markets Investment Trust Tetragon Financial Group
The Merchants Trust The North American Income Trust
The Scottish Investment Trust Tiso Blackstar Group
TR European Growth trust UK Commercial Property Trust
Utilico Emerging Markets Vietnam Holding Asset Management
Vietnam Infrastructure Fund VinaCapital Vietnam Opportunity Fund
VinaLand Vision Opportunity China Fund
WAM Active WAM Capital
WAM Research Witan Investment Trust
Witan Pacific Investment Trust Worldwide Healthcare Trust
YFM Equity Partners

Company news

£10000 into £31000 in three years: can this fund keep rising?

Wed, 24 Sep 2014 09:10:33 GMT

Are biotech funds set to bounce back over the rest of 2016?

Thu, 16 Jun 2016 11:11:14 GMT

Merricks: Why I'm buying the Biotech Growth Trust for my ISA

Mon, 17 Mar 2014 18:06:38 GMT

The good times aren't over for biotech

Thu, 22 Sep 2016 09:28:23 GMT

The Diary of a Private Investor: Biotech stands accused of being a bubble but ...

Thu, 16 Apr 2015 16:52:30 GMT

Investment summary

The Biotech Growth Trust (BIOG) is a specialist vehicle, aiming to generate long-term capital growth via investment in global biotech stocks. Following a particularly volatile period for the biotech industry, where concerns about drug pricing and investor risk aversion have weighed heavily on stock prices, the managers are hopeful that greater clarity regarding US healthcare policy will lead to continued improved performance of biotech stocks. Industry fundamentals remain attractive, including continued innovation and valuations are very supportive, which offers the potential for higher industry merger and acquisition activity.

Last updated on 21/02/2017

Key management

Andrew Joy, Chairman
Richard Klemm, Fund manager
Geoffrey Hsu, Fund manager

Company address

One Wood Street
London
EC2V 7WS
United Kingdom
View website